ANIXInvestor Event•prnewswire•
Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Sentiment:Negative (30)
Summary
SAN JOSE, Calif., Aug. 25, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that management will participate in the H.C. Wainwright 27th Annual Global...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 25, 2025 by prnewswire